Thomson Reuters

Insight: GSK vaccine ingredient scrutinized for narcolepsy clues

Share Slideshow
Photographer
FELIX ORDONEZ

A nurse holds a bottle of the Pandemrix H1N1 flu vaccine (R) and a bottle of the vaccine's adjuvant (L) at a health centre in Burgos in this November 16, 2009 file photo. REUTERS/Felix Ordonez/Files

A nurse holds a bottle of the Pandemrix H1N1 flu vaccine (R) and a bottle of the vaccine's adjuvant (L) at a health centre in Burgos in this November 16, 2009 file photo. REUTERS/Felix Ordonez/Files
Close
1 / 3
Photographer
JERRY LAMPEN

Bottles of adjuvants for use with the Pandemrix H1N1 flu vaccine are seen lined up during a vaccination programme in Schiedam in this November 23, 2009 file photo. REUTERS/Jerry Lampen/Files

Bottles of adjuvants for use with the Pandemrix H1N1 flu vaccine are seen lined up during a vaccination programme in Schiedam in this November 23, 2009 file photo. REUTERS/Jerry Lampen/Files
Close
2 / 3
Photographer
� Scanpix Sweden / Reuters

The first shipment of pandemic vaccine against the swine influenza A (H1N1) Pandemrix arrives in Malmo in this October 9, 2009 file photo. REUTERS/Scanpix

The first shipment of pandemic vaccine against the swine influenza A (H1N1) Pandemrix arrives in Malmo in this October 9, 2009 file photo. REUTERS/Scanpix
Close
3 / 3

All Collections

Migrant dinghy crossing

9:40am EDT

All Collections

The beautiful game

9:20am EDT

All Collections

Torrential floods in Texas

8:15am EDT

All Collections

Most powerful women

Tuesday, May 26, 2015

All Collections

Idlib's last stand

Tuesday, May 26, 2015

All Collections

Life's a beach

Tuesday, May 26, 2015

All Collections

Battle for Yemen

Tuesday, May 26, 2015

All Collections

Death in the jungle

Tuesday, May 26, 2015